Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
Estimated risk
CPSC doesn't classify recalls by risk, so Recall Relay estimated the risk as high from the hazard description. This is our estimate, not an official classification.
- Hazard
- The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- What to do
- Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.
- Products
-
- Mamisan Pain Relieving Topical Ointment
- Companies
- Plantimex, MiramarLab, Plantimex Distributors, Inc.
- Where it was sold
-
Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10.
Nationwide
- Barcodes
860006498115- Units affected
- About 50,330
- About this recall
- This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.